KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) EBT Margin (2016 - 2025)

Resmed (RMD) has disclosed EBT Margin for 17 consecutive years, with 34.87% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT Margin rose 224.0% year-over-year to 34.87%, compared with a TTM value of 33.69% through Dec 2025, up 254.0%, and an annual FY2025 reading of 32.6%, up 560.0% over the prior year.
  • EBT Margin was 34.87% for Q4 2025 at Resmed, up from 33.45% in the prior quarter.
  • Across five years, EBT Margin topped out at 34.87% in Q4 2025 and bottomed at 22.31% in Q4 2023.
  • Average EBT Margin over 5 years is 28.69%, with a median of 27.95% recorded in 2021.
  • The sharpest move saw EBT Margin tumbled -416bps in 2023, then skyrocketed 1032bps in 2024.
  • Year by year, EBT Margin stood at 26.52% in 2021, then decreased by 0bps to 26.48% in 2022, then decreased by -16bps to 22.31% in 2023, then soared by 46bps to 32.63% in 2024, then rose by 7bps to 34.87% in 2025.
  • Business Quant data shows EBT Margin for RMD at 34.87% in Q4 2025, 33.45% in Q3 2025, and 33.98% in Q2 2025.